RECURRENT WHO GRADE III GLIOMA
Clinical trials for RECURRENT WHO GRADE III GLIOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT WHO GRADE III GLIOMA trials appear
Sign up with your email to follow new studies for RECURRENT WHO GRADE III GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with deadly brain tumors: combination drug trial launches
Disease control Recruiting nowThis phase 2 trial is testing whether combining the drug ONC201 with other treatments (like paxalisib or a cancer-killing virus called DNX-2401) can help children and young adults with diffuse midline gliomas, a rare and aggressive brain cancer. The study enrolls 360 participants…
Matched conditions: RECURRENT WHO GRADE III GLIOMA
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New MRI technique could reveal hidden brain tumor activity
Knowledge-focused Recruiting nowThis study tests a new type of MRI scan that uses a special substance (hyperpolarized 13C pyruvate) to see how brain tumors use energy. Researchers want to know if this scan is safe and can show changes in tumor metabolism over time. About 300 people with low-grade gliomas will b…
Matched conditions: RECURRENT WHO GRADE III GLIOMA
Phase: PHASE1 • Sponsor: Susan Chang • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC